Drug intelligence / Profile preview

firocoxib

Development stage
Unknown
Lead developer
Boehringer Ingelheim
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

Firocoxib is a selective cyclooxygenase-2 (COX-2) inhibitor belonging to the coxib class of nonsteroidal anti-inflammatory drugs (NSAIDs). It is approved for veterinary use in dogs and horses, primarily for the management of pain and inflammation associated with osteoarthritis, as well as for perioperative pain and chronic musculoskeletal disorders. Firocoxib acts by selectively inhibiting COX-2-mediated prostaglandin synthesis, resulting in analgesic, anti-inflammatory, and antipyretic effects. Its selectivity for COX-2 over COX-1 reduces the risk of gastrointestinal side effects commonly seen with non-selective NSAIDs. Firocoxib was the first COX-2 inhibitor approved by the FDA for use in horses. It is not intended or approved for human medicine[3][4][5][6].

Brand names
PrevicoxEquioxx
Other names
EquiCoxib oral solutionEquiCoxib (firocoxib) oral solution
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on firocoxib.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on firocoxib.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call